Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-23 | Richard D. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. |
| 2015-04-15 | Mr. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. |
| 2016-04-29 | Mr. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. Since 2015, Mr. Peterson has served as Chief Financial Officer of Novan, Inc., a privately-held pharmaceutical company. |
| 2017-04-28 | Mr. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. Mr. Peterson is currently the Chief Financial Officer of Sienna Biopharmaceuticals, Inc. |
| 2018-04-27 | Mr. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. Mr. Peterson is currently the Chief Financial Officer of Dermavant Sciences, Inc. |
| 2019-04-29 | Richard D. Petersonbecame a director of the Company in 2014. Mr. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. Mr. Peterson served as the Chief Financial Officer of Dermavant Sciences, Inc., a position he held from 2018 to 2019. From 2017 to 2018, Mr. Peterson was the Chief Financial Officer of Sienna Biopharmaceuticals, Inc., a public pharmaceutical company. |
| 2020-04-29 | Mr. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. |
| 2021-04-29 | Mr. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. Since February 2021, Mr. Peterson has served as the Chief Financial Officer of Clarus Therapeutics, a specialty pharmaceutical company. |
| 2022-04-29 | Mr. Peterson has over 20 years of experience in the areas of executive management, finance and accounting. Since February 2021, Mr. Peterson has served as the Chief Financial Officer of Clarus Therapeutics, a specialty pharmaceutical company. |
| 2023-04-28 | Mr. Peterson has over 20 years of experience in executive management, finance and accounting. He has served as Chief Financial Officer of various biotech companies. |
| 2024-04-26 | Mr. Peterson has over 20 years of experience in executive management, finance and accounting. |
Data sourced from SEC filings. Last updated: 2025-10-11